Genetic modification rules and limited access to capital are holding biotech R&D back, group says
BiotechNZ, a group representing companies and research bodies, has embarked on a campaign to increase investment in biotechnology research and change the rules around research into genetically modified materials.
A BiotechNZ report on the future of biotechnology in New Zealand says that access to capital and rules on genetic modification are the most significant constraints on local R&D. On 11 February in Dunedin, it held the first in a series of seminars aimed at boosting biotechnology in the country.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.